Publikasi Scopus 2024 per tanggal 30 Juni 2024 (499 artikel)

Sihombing U.H.M.; Andrijono A.; Purwoto G.; Gandamihardja S.; Harahap A.R.; Rustamadji P.; Kekalih A.; Widyawati R.; Fuady D.R.
Sihombing, Unedo Hence Markus (57741696900); Andrijono, Andrijono (36704391000); Purwoto, Gatot (14720170400); Gandamihardja, Supriadi (54880603300); Harahap, Alida R. (6507325543); Rustamadji, Primariadewi (55321572200); Kekalih, Aria (55633562200); Widyawati, Retno (57212476754); Fuady, Dzicky Rifqi (57198896312)
57741696900; 36704391000; 14720170400; 54880603300; 6507325543; 55321572200; 55633562200; 57212476754; 57198896312
Correction to: Cancer Stem Cells (CD44+/CD24−), RAD6, DDB2 Immunohistochemistry Expression and IHC-UNEDO Scoring System As Predictor of Ovarian Cancer Chemoresistance (The Journal of Obstetrics and Gynecology of India, (2023), 10.1007/s13224-023-01829-w)
2024
Journal of Obstetrics and Gynecology of India
0
Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Tarakan Hospital, Jakarta, Indonesia; Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Hasan Sadikin Hospital, Universitas Padjadjaran, Bandung, Indonesia; Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Anatomic Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Occupational Medicine Division, Community Medicine Department, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Anatomic Pathology, Budhi Asih Hospital, Jakarta, Indonesia; Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Department of Obstetrics and Gynecology, Karawang General Public Hospital, Karawang, Indonesia; Doctoral Program in Medical Sciences Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
Sihombing U.H.M., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Tarakan Hospital, Jakarta, Indonesia, Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Doctoral Program in Medical Sciences Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Andrijono A., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Purwoto G., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Gandamihardja S., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Hasan Sadikin Hospital, Universitas Padjadjaran, Bandung, Indonesia; Harahap A.R., Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Rustamadji P., Department of Anatomic Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Kekalih A., Occupational Medicine Division, Community Medicine Department, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Widyawati R., Department of Anatomic Pathology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Department of Anatomic Pathology, Budhi Asih Hospital, Jakarta, Indonesia; Fuady D.R., Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Tarakan Hospital, Jakarta, Indonesia, Department of Obstetrics and Gynecology, Karawang General Public Hospital, Karawang, Indonesia
The graphical abstract published in the earlier version of the article has been removed. It was an inadvertent error occurred at the production stage and unfortunately overlooked during the successive correction stages as well. The original article has been corrected. © Federation of Obstetric & Gynecological Societies of India 2024.
adult; cancer stem cell; drug resistance; drug therapy; erratum; female; human; immunohistochemistry; ovary cancer; scoring system
Springer
09719202
Erratum
Q3
286
15584